Page last updated: 2024-10-31

apnea and Weight Gain

apnea has been researched along with Weight Gain in 14 studies

Apnea: A transient absence of spontaneous respiration.

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research Excerpts

ExcerptRelevanceReference
"We randomly assigned 2006 infants with birth weights of 500 to 1250 g during the first 10 days of life to receive either caffeine or placebo, until drug therapy for apnea of prematurity was no longer needed."9.12Caffeine therapy for apnea of prematurity. ( Barrington, KJ; Davis, P; Doyle, LW; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2006)
"In this blinded, randomized, placebo-controlled study, we found that infants who received supplemental carnitine did not demonstrate any reduction in apnea of prematurity, ventilator or nasal continuous positive airway pressure days, or the need for supplemental oxygen therapy."9.10Role of L-carnitine in apnea of prematurity: a randomized, controlled trial. ( Barrington, KJ; Barshop, BA; Finer, NN; O'Donnell, J; Rich, W, 2002)
"This study determined the effect of modifying a single aspect of the intermediate care environment on the incidence of apnea and rate of weight gain in convalescent preterm infants."9.08Effect of standard rest periods on apnea and weight gain in preterm infants. ( D'Auria, J; Holditch-Davis, D; O'Hale, A; Torres, C, 1997)
"Our aim was to assess the safety and efficacy of transpyloric tube feeding as a therapeutic option to reduce apnea and bradycardia in hospitalized very low birthweight (VLBW) infants with clinical signs suggestive of gastroesophageal reflux (GER)."7.75Transpyloric tube feeding in very low birthweight infants with suspected gastroesophageal reflux: impact on apnea and bradycardia. ( Cotten, CM; Goldberg, RN; Malcolm, WF; Mears, S; Smith, PB, 2009)
"We randomly assigned 2006 infants with birth weights of 500 to 1250 g during the first 10 days of life to receive either caffeine or placebo, until drug therapy for apnea of prematurity was no longer needed."5.12Caffeine therapy for apnea of prematurity. ( Barrington, KJ; Davis, P; Doyle, LW; Ohlsson, A; Roberts, RS; Schmidt, B; Solimano, A; Tin, W, 2006)
"In this blinded, randomized, placebo-controlled study, we found that infants who received supplemental carnitine did not demonstrate any reduction in apnea of prematurity, ventilator or nasal continuous positive airway pressure days, or the need for supplemental oxygen therapy."5.10Role of L-carnitine in apnea of prematurity: a randomized, controlled trial. ( Barrington, KJ; Barshop, BA; Finer, NN; O'Donnell, J; Rich, W, 2002)
"To determine the effect of indwelling versus intermittent feeding tube placement on weight gain, apnea, and bradycardia in premature neonates."5.08Indwelling versus intermittent feeding tubes in premature neonates. ( Ballantyne, M; Pinelli, J; Stevens, B; Symington, A, 1995)
"This study determined the effect of modifying a single aspect of the intermediate care environment on the incidence of apnea and rate of weight gain in convalescent preterm infants."5.08Effect of standard rest periods on apnea and weight gain in preterm infants. ( D'Auria, J; Holditch-Davis, D; O'Hale, A; Torres, C, 1997)
"01), apnea/bradycardia (heart rate less than 90/min) requiring intervention to increase the heart rate (P less than ."5.06A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age. ( Christensen, RD; Kimura, RE; Koenig, JM; Noble, NA; Ross, MP; Rothstein, G; Simmons, MA, 1989)
"Our aim was to assess the safety and efficacy of transpyloric tube feeding as a therapeutic option to reduce apnea and bradycardia in hospitalized very low birthweight (VLBW) infants with clinical signs suggestive of gastroesophageal reflux (GER)."3.75Transpyloric tube feeding in very low birthweight infants with suspected gastroesophageal reflux: impact on apnea and bradycardia. ( Cotten, CM; Goldberg, RN; Malcolm, WF; Mears, S; Smith, PB, 2009)
" After a postsurgery recovery of at least 7 days, we studied all animals to detect the presence of apnea and the consequences of it, if any."3.69Age-dependent vulnerability to carotid chemodenervation in piglets. ( Côté, A; Meehan, B; Porras, H, 1996)
"To identify dosing strategies that will assure stable caffeine concentrations in preterm neonates despite changing caffeine clearance during the first 8 weeks of life."1.46Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates. ( Datta, AN; Jost, K; Koch, G; Pfister, M; Schulzke, SM; van den Anker, J, 2017)

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19901 (7.14)18.7374
1990's5 (35.71)18.2507
2000's5 (35.71)29.6817
2010's3 (21.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koch, G1
Datta, AN1
Jost, K1
Schulzke, SM1
van den Anker, J1
Pfister, M1
Matagne, V1
Ehinger, Y1
Saidi, L1
Borges-Correia, A1
Barkats, M1
Bartoli, M1
Villard, L1
Roux, JC1
Barrington, KJ3
Fortin-Pellerin, E1
Pennaforte, T1
Malcolm, WF1
Smith, PB1
Mears, S1
Goldberg, RN1
Cotten, CM1
Schmidt, B1
Roberts, RS1
Davis, P1
Doyle, LW1
Ohlsson, A1
Solimano, A1
Tin, W1
Coulter, DM1
Stevenson, DK1
Symington, A1
Ballantyne, M1
Pinelli, J1
Stevens, B1
Riordan, LL1
Kelly, DH1
Shannon, DC1
Côté, A1
Porras, H1
Meehan, B1
Torres, C1
Holditch-Davis, D1
O'Hale, A1
D'Auria, J1
Waite, A1
Emery, J1
Taylor, E1
Carpenter, R1
Gardner, A1
O'Donnell, J1
Finer, NN1
Rich, W1
Barshop, BA1
Ross, MP1
Christensen, RD1
Rothstein, G1
Koenig, JM1
Simmons, MA1
Noble, NA1
Kimura, RE1

Clinical Trials (10)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Feasibility and Safety of Duodenal Feeds in Very Low Birth Weight Infants[NCT04246333]30 participants (Anticipated)Interventional2020-08-07Recruiting
A Prospective, Controlled Trial of Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea of Prematurity[NCT01911182]Phase 2/Phase 37 participants (Actual)Interventional2011-10-31Terminated (stopped due to Low recruitment rate)
High Versus Low Dose Caffeine as Respiratory Stimulant in Preterm Infants[NCT04144712]Phase 180 participants (Anticipated)Interventional2019-04-01Recruiting
Efficacy and Safety of Methylxanthines in Very Low Birthweight Infants[NCT00182312]Phase 32,000 participants (Anticipated)Interventional1999-10-31Completed
Long-Term Effects On Sleep Of Methylxanthine Therapy For Apnea Of Prematurity[NCT01020357]Phase 3201 participants (Actual)Interventional2009-11-30Completed
[NCT01066728]Phase 2/Phase 387 participants (Actual)Interventional2001-08-31Completed
Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia[NCT04447989]Phase 2120 participants (Anticipated)Interventional2021-05-27Recruiting
A Randomized, Placebo-controlled Trial of Early Caffeine in Preterm Neonates[NCT03086473]Phase 424 participants (Actual)Interventional2017-02-01Active, not recruiting
Pharmacokinetics (PK) and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia[NCT05295784]Phase 118 participants (Anticipated)Interventional2024-06-30Not yet recruiting
Correlation Between Carnitine Deficiency and Hypoglycemic Events in Type I Diabetes; Effects of Carnitine Supplementation on Hypoglycemic Events in Type I Diabetes[NCT00351234]200 participants (Actual)Observational2004-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for apnea and Weight Gain

ArticleYear
Fluid restriction for treatment of preterm infants with chronic lung disease.
    The Cochrane database of systematic reviews, 2017, 02-08, Volume: 2

    Topics: Apnea; Bronchopulmonary Dysplasia; Chronic Disease; Fluid Therapy; Humans; Infant, Newborn; Infant,

2017

Trials

5 trials available for apnea and Weight Gain

ArticleYear
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Caffeine therapy for apnea of prematurity.
    The New England journal of medicine, 2006, May-18, Volume: 354, Issue:20

    Topics: Apnea; Bronchopulmonary Dysplasia; Caffeine; Central Nervous System Stimulants; Combined Modality Th

2006
Indwelling versus intermittent feeding tubes in premature neonates.
    Journal of obstetric, gynecologic, and neonatal nursing : JOGNN, 1995, Volume: 24, Issue:4

    Topics: Apnea; Bradycardia; Catheterization; Catheters, Indwelling; Enteral Nutrition; Humans; Infant, Newbo

1995
Effect of standard rest periods on apnea and weight gain in preterm infants.
    Neonatal network : NN, 1997, Volume: 16, Issue:8

    Topics: Apnea; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Neonatal Nursing; Re

1997
Role of L-carnitine in apnea of prematurity: a randomized, controlled trial.
    Pediatrics, 2002, Volume: 109, Issue:4

    Topics: Aminophylline; Apnea; Carnitine; Dietary Supplements; Humans; Infant, Newborn; Infant, Premature, Di

2002
A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age.
    Journal of perinatology : official journal of the California Perinatal Association, 1989, Volume: 9, Issue:3

    Topics: Anemia, Neonatal; Apnea; Blood Transfusion; Bradycardia; Erythrocyte Transfusion; Erythropoiesis; He

1989

Other Studies

8 other studies available for apnea and Weight Gain

ArticleYear
Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
    The Journal of pediatrics, 2017, Volume: 191

    Topics: Apnea; Birth Weight; Caffeine; Central Nervous System Stimulants; Citrates; Dose-Response Relationsh

2017
A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome.
    Neurobiology of disease, 2017, Volume: 99

    Topics: Amines; Animals; Apnea; Codon; Cyclohexanecarboxylic Acids; Dependovirus; Disease Models, Animal; Di

2017
Transpyloric tube feeding in very low birthweight infants with suspected gastroesophageal reflux: impact on apnea and bradycardia.
    Journal of perinatology : official journal of the California Perinatal Association, 2009, Volume: 29, Issue:5

    Topics: Apnea; Bradycardia; Child Development; Cohort Studies; Enteral Nutrition; Enterocolitis, Necrotizing

2009
Caffeine for apnea of prematurity.
    The New England journal of medicine, 2006, Aug-31, Volume: 355, Issue:9

    Topics: Apnea; Caffeine; Central Nervous System Stimulants; Diuresis; Growth; Humans; Infant, Low Birth Weig

2006
On the caffeination of prematurity.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Apnea; Caffeine; Central Nervous System Stimulants; Developmental Disabilities; Humans; Infant, Newb

2007
Slow weight gain is associated with increased periodic breathing in healthy infants.
    Pediatric pulmonology, 1994, Volume: 17, Issue:1

    Topics: Apnea; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Reference Values; Weight Gain

1994
Age-dependent vulnerability to carotid chemodenervation in piglets.
    Journal of applied physiology (Bethesda, Md. : 1985), 1996, Volume: 80, Issue:1

    Topics: Aging; Anesthesia; Animals; Animals, Newborn; Apnea; Blood Gas Analysis; Body Temperature; Carotid B

1996
The comparative costs of care using apnoea monitors and scales in families with a cot death.
    Health trends, 1993, Volume: 25, Issue:1

    Topics: Apnea; Child Health Services; Child, Preschool; Consumer Behavior; Durable Medical Equipment; Home C

1993